Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
16.80
-0.18 (-1.06%)
Jul 22, 2024, 10:03 AM EDT - Market open
Entrada Therapeutics Employees
Entrada Therapeutics had 159 employees as of December 31, 2023. The number of employees increased by 29 or 22.31% compared to the previous year.
Employees
159
Change (1Y)
29
Growth (1Y)
22.31%
Revenue / Employee
$1,024,358
Profits / Employee
$147,704
Market Cap
629.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 159 | 29 | 22.31% |
| Dec 31, 2022 | 130 | 16 | 14.04% |
| Dec 31, 2021 | 114 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pediatrix Medical Group | 5,450 |
| PetIQ | 1,933 |
| Ginkgo Bioworks Holdings | 1,218 |
| Phathom Pharmaceuticals | 452 |
| REGENXBIO | 344 |
| Prime Medicine | 234 |
| IGM Biosciences | 224 |
| KalVista Pharmaceuticals | 150 |
TRDA News
- 4 weeks ago - Entrada Therapeutics Announces $100 Million Registered Direct Offering - GlobeNewsWire
- 4 weeks ago - Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy - GlobeNewsWire
- 7 weeks ago - Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - Entrada Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Entrada Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Entrada Therapeutics, Inc. - TRDA - PRNewsWire